Waters Corporation introduced the first in a new line of size exclusion chromatography (SEC) columns aimed at improving the analysis while lowering the cost of gene therapies, specifically adeno-associated viral (AAV) vectors.
Risk Adjusted Net Present Value: What is the current valuation of Zai Lab’s (Trospium chloride + Xanomeline)
The revenue for (Trospium chloride + Xanomeline) is expected to reach an annual total of $761 mn by 2033 globally based off GlobalData’s Expiry Model.